Notably, the FDA approved the oral Wegovy pill, offering a convenient alternative for those preferring not to use injections
March ushered in the first wave of off-patent competition for semaglutide, the active ingredient in Ozempic and Wegovy, marking a global turning point in metabolic medicine
Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
Tirzepatide, a dual GIP/GLP-1 agonist, showed up to 20.9% average weight loss in SURMOUNT-1 at 72 weeks
On the other hand, Mod GRF has GHRH receptor affinity due to its apparent similarity to the shortest functional part of the GHRH GHF (1-29)
For people with normally functioning thyroids who do not take levothyroxine, tirzepatide is unlikely to cause clinically significant thyroid problems